• OPEN AN ACCOUNT
Indian Indices
Sensex
77,656.09 286.98
( 0.37%)
Global Indices
Nasdaq
53,588.00 149.84
(0.28%)
Dow Jones
7,696.83 22.97
(0.30%)
Hang Seng
65,802.43 274.34
(0.42%)
Nikkei 225
10,884.15 29.83
(0.27%)
Forex
USD-INR
95.63 -0.04
(-0.04%)
EUR-INR
111.66 -0.10
(-0.09%)
GBP-INR
130.46 0.10
(0.08%)
JPY-INR
0.60 0.00
(-0.21%)

EQUITY - MARKET SCREENER

Concord Biotech Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543960
INE338H01029
193.0629905
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CONCORDBIO
56.99
16205.05
EPS(TTM)
Face Value()
Div & Yield %
27.18
1
0.49
 

palred technologies ltd
Ridhi Synthetics standalone net profit declines 11.76% in the March 2026 quarter
May 28,2026
Net profit of Ridhi Synthetics declined 11.76% to Rs 0.15 crore in the quarter ended March 2026 as against Rs 0.17 crore during the previous quarter ended March 2025. Sales rose 9.09% to Rs 0.12 crore in the quarter ended March 2026 as against Rs 0.11 crore during the previous quarter ended March 2025.

For the full year,net profit declined 25.23% to Rs 0.80 crore in the year ended March 2026 as against Rs 1.07 crore during the previous year ended March 2025. Sales rose 16.28% to Rs 0.50 crore in the year ended March 2026 as against Rs 0.43 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.120.11 9 0.500.43 16
OPM %-33.33-45.45 --28.00-34.88 -
PBDT0.210.23 -9 1.131.48 -24
PBT0.190.22 -14 1.061.43 -26
NP0.150.17 -12 0.801.07 -25